Moderna Stock Soars Amid Bird Flu and COVID-19 Surge
Moderna shares jumped nearly 12% as the first US bird flu death and rising COVID-19 cases drive investor interest. Explore the factors influencing Moderna's growth.
Moderna surged nearly 12% following the first US bird flu death and increased COVID-19 cases.